| Cat.No. | Name | Information |
|---|---|---|
| M1973 | Ostarine (MK-2866) | Ostarine (GTx-024 and MK-2866) is an investigational selective androgen receptor modulator (SARM) with Ki of 3.8 nM. |
| M6033 | Dihydrotestosterone | Dihydrotestosterone is an androgen (male hormone). Specifically it's the strongest of the androgens. It can be used to construct animal models of polycystic ovary syndrome (PCOS). |
| M6105 | Testosterone | Testosterone is an androgen, which binds the androgen receptor. |
| M5565 | Dexmedetomidine HCl | Dexmedetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is used in veterinary medicine for its analgesic and sedative properties. |
| M5805 | Nandrolone | Nandrolone is a synthetic, anabolic steroid analog of testosterone. |
| M1839 | MDV3100 | MDV3100 is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. |
| M5764 | Medroxyprogesterone acetate | Medroxyprogesterone acetate (MPA) is a synthetic progestin and act as a potent progesterone receptor agonist, used to treat abnormal menstruation or irregular vaginal bleeding. |
| M2270 | Apalutamide (ARN-509) | Apalutamide (ARN-509) is a novel androgen receptor (AR) antagonist for the treatment of castration-resistant prostate cancer (CRPC). |
| M10306 | Bavdegalutamide (ARV-110) | Bavdegalutamide (ARV-110) is an oral, specific androgen receptor (AR) PROTAC degrader. |
| M14618 | LY2452473 | LY2452473 is an orally bioavailable, selective androgen receptor modulator (SARM). |
| M14617 | GLPG0492 | GLPG0492 is a non-steroidal selective androgen receptor modulator (potency 12 nM). GLPG0492 has the potential for the research of musculo-skeletal diseases such as sarcopenia and cachexia. |
| M14616 | Dehydroisoandrosterone 3-acetate | Dehydroepiandrosterone 3-acetate is a testosterone/estrogen precursor and known modulator of vertebrate aggression. |
| M14615 | BMS-564929 | BMS-564929 is an androgen receptor (AR) agonist, binds to androgen receptor (AR) with a Ki of 2.11±0.16 nM. |
| M14614 | ACP-105 | ACP-105 is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively. |
| M14613 | 3,3'-Diindolylmethane | 3,3'-Diindolylmethane is a strong, pure androgen receptor (AR) antagonist. |
| M11020 | Proxalutamide | Proxalutamide (GT0918) is an antagonist of the androgen receptor (AR) with oral activity. Proxalutamide (GT0918) can be used in prostate cancer and COVID-19 research. |
| M10961 | Ralaniten triacetate | Ralaniten triacetate (EPI-506), a prodrug for Ralaniten, is a pioneering, orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor. Ralaniten triacetate is active against full-length and resistance-related AR species, including AR-v7. |
| M10960 | Ralaniten | Ralaniten (EPI-002) is an effective and orally active androgen receptor N-terminal domain (AR-NTD) antagonist. Ralaniten inhibits AR transcriptional activity,IC50 The value is 7.4 μM. Ralanites can be used in the study of castration-resistant prostate cancer (CRPC). |
| M10958 | JNJ-63576253 | JNJ-63576253 (TRC-253) is a potent and orally active complete antagonist of the androgen receptor against F877L mutant AR and wild-type AR in LNCaP cells IC50 The values are 37 and 54 nM, respectively. JNJ-63576253 can be used in the study of castration-resistant prostate cancer (CRPC). |
| M10392 | ACTH (1-39) TFA | ACTH (1-39) TFA is a polypeptide hormone extracted from the anterior lobe of the pituitary gland of mammals, acts on the adrenal cortex, and has the effect of promoting the proliferation of adrenal cortex tissue and the production and secretion of corticosteroids. |
| M10306 | Bavdegalutamide (ARV-110) | Bavdegalutamide (ARV-110) is an oral, specific androgen receptor (AR) PROTAC degrader. |
| M9956 | Darolutamide | Darolutamide (ODM-201) is a new-generation, potent and selective androgen receptor (AR) inhibitor. |
| M9149 | MI-136 | MI-136 inhibits DHT-induced expression of androgen receptor (AR) target genes. |
| M8908 | ASC-J9 | ASC-J9, also known as GO-Y025 and Dimethylcurcumin, suppressesing castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors. |
| M7880 | 11-Ketotestosterone | 11-Ketotestosterone is a minor androgen in humans, but a major androgen in fish. |
| M7831 | Hydroxyflutamide | Hydroxflutamide is the active metabolite of Flutamide and a potent androgen receptor (AR) antagonist with an IC50 value of 700 nM.It can be used in prostate cancer studies. |
| M7561 | GSK-2881078 | GSK-2881078 is an orally active and nonsteroidal selective androgen receptor modulator (SARM) which act as partial AR agonists in androgenic tissues while mainly as complete AR agonists in synthetic metabolic tissues,induces AR-mediated transcriptional activation in PC3(AR)2 cells (EC50 = 3.99 nM). |
| M6269 | Indacaterol | Indacaterol is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol inhibits NF-κB activity in a β-arrestin2-dependent manner. |
| M6123 | Nandrolone phenylpropionate | Nandrolone phenylpropionate (NPP) is an anabolic-androgenic steroid. The low androgenicity and enhanced anabolic activity of NPP has shown to positively influence calcium metabolism and to increase bone mass in osteoporosis. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
